Displaying drugs 251 - 275 of 2784 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Thiabendazole | 201.248 C10H7N3S | A benzimidazole used in the treatment of strongyloides, cutaneous larva migrans, visceral larva migrans, and trichinosis infections. | Benzimidazole Derivatives / Imidazole and Triazole Derivatives | |
Theophylline | 180.164 C7H8N4O2 | A xanthine used to manage the symptoms of asthma, COPD, and other lung conditions caused by reversible airflow obstruction. | Xanthines and Adrenergics | |
Thenyldiamine | 261.39 C14H19N3S | An ingredient in products indicated to treat rhinitis caused by the common cold. | Not Annotated | |
Thenalidine | 286.435 C17H22N2S | Withdrawn from the Canadian, US, and UK markets in 1963 due to concerns involving neutropenia. | Antihistamines for Topical Use | |
Thallous chloride Tl-201 | 236.42 ClTl | A radioisotope indicated for cardiac perfusion scintigraphy | Diagnostic Radiopharmaceuticals | |
Thallous chloride | 239.836 ClTl | A diagnostic radiopharmaceutical for myocardial perfusion testing and tests of parathyroid function. | Radioactive Diagnostic Agent | |
Thalidomide | 258.2295 C13H10N2O4 | A medication used to treat cancers, particularly newly diagnosed multiple myeloma, and erythema nodosum leprosum. | Angiogenesis Inhibitors / Drugs causing inadvertant photosensitivity / Leprostatic Agents / Phthalimides / Teratogens | |
Tezacaftor | 520.505 C26H27F3N2O6 | A medication used to treat homozygous or heterozygous F508del mutation cystic fibrosis. | BCRP/ABCG2 Inhibitors / BCRP/ABCG2 Substrates / Cytochrome P-450 CYP1A2 Inhibitors / Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) / Cytochrome P-450 CYP2B6 Inhibitors / Cytochrome P-450 CYP2B6 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2D6 Inhibitors / Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Inducers / Cytochrome P-450 CYP3A5 Inducers (strength unknown) / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Dioxoles / Heterocyclic Compounds, Fused-Ring / OAT1/SLC22A6 inhibitors / OAT3/SLC22A8 Inhibitors / OATP1B1/SLCO1B1 Inhibitors / OATP1B1/SLCO1B1 Substrates / OATP1B3 inhibitors / OCT2 Inhibitors / P-glycoprotein inhibitors / P-glycoprotein substrates | |
Tetryzoline | 200.285 C13H16N2 | An alpha-adrenergic agonist used in the temporary symptomatic relief of discomfort and redness of the eyes due to minor irritations, as well as alleviate nasal congestion. | Sympathomimetics Used as Decongestants / Sympathomimetics, Plain | |
Tetrofosmin | 382.462 C18H40O4P2 | A diphosphine complexed with technetium 99 used for imaging to determine myocardial ischemia, infarcted myocardium, and assessment of left ventricular function. | Radioactive Diagnostic Agent | |
Tetramethylthiuram monosulfide | 208.36 C6H12N2S3 | Not Annotated | Standardized Chemical Allergen | |
Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate | 602.99 C24H44BCuF4N4O4 | Tetrakis (2-methoxyisobutylisocyanide) copper (I) tetrafluoroborate is a component of Cardiolite, a technetium Tc99m-based imaging agent used for assessing myocardial perfusion. | Not Annotated | |
Tetraferric tricitrate decahydrate | 967.803 C18H32Fe4O31 | A phosphate binder used to control serum phosphorus levels or as an iron supplement. | Drugs for Treatment of Hyperkalemia and Hyperphosphatemia | |
Tetradecyl hydrogen sulfate (ester) | 294.45 C14H30O4S | An anionic surfactant used to treat small uncomplicated varicose veins. | Drugs that are Mainly Renally Excreted | |
Tetracycline phosphate complex | 4821.729 C198H225N18NaO102P10 | Not Annotated | Anti-Bacterial Agents | |
Tetracycline | 444.4346 C22H24N2O8 | An antibiotic used to treat a wide variety of susceptible infections. | Antiinfectives and Antiseptics for Local Oral Treatment | |
Tetracosactide | 2933.49 C136H210N40O31S | A diagnostic agent used in the screening of patients presumed to have adrenocortical insufficiency. | Adrenocorticotropic Hormone / Hormones | |
Tetrachlorodecaoxide | 319.821 Cl4H2O11 | Investigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections, cancer/tumors (unspecified), HIV infection, and inflammatory disorders (unspecified). | Radiation-Protective Agents | |
Tetracaine | 264.369 C15H24N2O2 | A local anaesthetic agent used to induce local analgesia in the eyes and skin during medical procedures. | Anesthetics for Topical Use / Esters of Aminobenzoic Acid | |
Tetrabenazine | 317.4226 C19H27NO3 | A vesicular monoamine transporter 2 (VMAT) inhibitor used for the management of chorea associated with Huntington's Disease. | Quinolizines / Vesicular Monoamine Transporter 2 Inhibitor | |
Testosterone undecanoate | 456.711 C30H48O3 | An androgen indicated for testosterone replacement therapy in adult males with primary hypogonadism and hypogonadotropic hypogonadism. | Androgens | |
Testosterone propionate | 344.4877 C22H32O3 | A slow-release anabolic steroid no longer used commonly for the treatment of androgen deficiency or promotion of anabolic effects on muscles. | Androgens / Testosterone Congeners | |
Testosterone enanthate | 400.594 C26H40O3 | An androgen used to treat low or absent testosterone. | Androgens | |
Testosterone enantate benzilic acid hydrazone | 624.866 C40H52N2O4 | Not Annotated | Androstanes / Androstenes / Androstenols / Fused-Ring Compounds / Gonadal Hormones / Gonadal Steroid Hormones / Hormones / Hormones, Hormone Substitutes, and Hormone Antagonists / Steroids / Testosterone and derivatives / Testosterone Congeners | |
Testosterone cypionate | 412.614 C27H40O3 | An androgen used to treat low or absent testosterone. | Anabolic Agents / Androgens / Delayed-Action Preparations |
Displaying drugs 251 - 275 of 2784 in total